IFN-β decreases serum levels of cytokines such as TNF-α [88] as well as MMP-9 activity and the ratio of MMP-9 and TIMP-1 (an endogenous inhibitor of MMP-9) in blood samples in multiple sclerosis [61,62]. Here, IFNB1 is linked to multiple sclerosis.